Mutations in PIK3CA Sensitize Breast Cancer Cells to Physiologic Levels of Aspirin - (:unkn) unknown (My University, 2016)
Keywords: Female; Humans; Prognosis; Mutation; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Phosphatidylinositol 3-Kinases; Class I Phosphatidylinositol 3-Kinases